Red Light Therapy for Vertigo & Balance

Vertigo — the false sensation that you or your surroundings are spinning — affects an estimated 15–20% of adults at some point in their lives. It can be profoundly disabling, causing nausea, falls, inability to work, and significant anxiety. The most common causes are benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and Meniere’s disease.

Red light therapy is occasionally suggested for vertigo and balance disorders. This page examines whether there is any scientific basis for this claim.

Types of vertigo and their causes

BPPV (benign paroxysmal positional vertigo)

BPPV is the most common cause of vertigo, accounting for approximately 50% of cases. It is caused by displaced otoconia (calcium carbonate crystals) in the semicircular canals of the inner ear. These crystals inappropriately stimulate hair cells, creating a false sense of movement.

Treatment is the Epley manoeuvre (or similar canalith repositioning procedures) — a series of head movements that physically relocate the crystals. This is effective in 80–90% of cases and requires no medication or technology.

There is no plausible mechanism by which red light therapy would affect calcium carbonate crystals in the semicircular canals. PBM cannot physically reposition otoconia.

Vestibular neuritis and labyrinthitis

These conditions involve inflammation of the vestibular nerve or inner ear structures, often following a viral infection. Symptoms include sudden severe vertigo lasting days to weeks, with gradual recovery through vestibular compensation.

Treatment includes corticosteroids (for acute inflammation), vestibular rehabilitation exercises, and symptomatic relief (antiemetics, vestibular suppressants).

Here, PBM’s anti-inflammatory properties have at least a theoretical rationale — reducing vestibular nerve inflammation could theoretically speed recovery. But the inner ear is encased in the temporal bone (one of the densest bones in the body), and delivering therapeutic light doses to the vestibular apparatus through bone is extremely challenging.

Meniere’s disease

Meniere’s disease involves episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness. It is thought to be caused by endolymphatic hydrops (excess fluid in the inner ear). The exact pathophysiology remains debated.

Treatment includes dietary sodium restriction, diuretics, betahistine, intratympanic gentamicin or steroids, and rarely surgery.

Again, the inner ear location makes direct PBM delivery problematic.

Central vertigo

Vertigo caused by brainstem or cerebellar pathology (stroke, tumour, MS) requires urgent neurological evaluation and treatment. PBM has no role here.

The evidence for PBM and vertigo

Direct evidence

There are no published RCTs examining PBM for vertigo or balance disorders. The evidence base is effectively empty.

A very small number of reports exist in the grey literature (conference abstracts, case reports, non-peer-reviewed sources), but nothing that meets the standard for clinical evidence.

Related evidence

PBM and tinnitus

Tinnitus and vertigo often coexist (particularly in Meniere’s disease), and PBM for tinnitus has been studied slightly more. A few small trials have examined LLLT applied to the mastoid bone (behind the ear) or directly into the ear canal for tinnitus, with mixed results. See our tinnitus page for details.

The relevance to vertigo is indirect — if PBM can reach the inner ear (questionable given bone attenuation) and reduce inflammation or improve cochlear/vestibular blood flow, both tinnitus and vertigo symptoms could theoretically improve. But this is speculation built on limited tinnitus data, which itself is inconclusive.

PBM and inner ear blood flow

The inner ear is supplied by the labyrinthine artery, a branch of the anterior inferior cerebellar artery. Reduced blood flow is implicated in some forms of hearing loss and vestibular dysfunction.

PBM’s vasodilatory effects (via nitric oxide release) could theoretically improve inner ear blood flow, but whether therapeutic light can reach the labyrinthine artery through the temporal bone is doubtful. The temporal bone attenuates light significantly, and the dose reaching the inner ear would be a tiny fraction of the surface dose.

PBM and balance in older adults

A slightly more relevant line of evidence comes from studies on PBM and balance in older adults, though these typically address muscle function and proprioception rather than vestibular function:

Amorim et al. (2018) examined PBM applied to lower limb muscles in older adults and found modest improvements in balance measures. However, this was related to improved muscle performance and postural control, not vestibular function. The improvement was in stability, not vertigo.

The vestibular delivery problem

The fundamental challenge for PBM in vestibular conditions is anatomical. The vestibular apparatus (semicircular canals, utricle, saccule) is embedded within the petrous part of the temporal bone — one of the hardest, densest bones in the human body.

Even near-infrared light (810–850nm), which has the deepest penetration of any PBM wavelength, is heavily attenuated by bone. The temporal bone is approximately 2–3mm thick at its thinnest and over 10mm at its thickest. Photon delivery to the inner ear through transcutaneous application would be minimal.

Trans-tympanic delivery (through the eardrum) is theoretically possible and has been explored for tinnitus research, but the eardrum and middle ear structures would still attenuate the light before it reached the vestibular structures.

A practical assessment

What PBM cannot do for vertigo

• Reposition displaced otoconia (BPPV) — This is a physical/mechanical problem
• Replace medical treatment for acute vestibular neuritis — Corticosteroids are the evidence-based treatment
• Treat Meniere’s disease — The pathophysiology is complex and inaccessible to external light
• Address central causes of vertigo — These require neurological investigation and treatment

What PBM might theoretically do (unproven)

• Reduce vestibular nerve inflammation (if light can reach it — questionable)
• Improve inner ear microcirculation (if light can reach it — questionable)
• Reduce post-vestibular headache and neck pain (as a secondary symptom)
• Improve muscle-mediated balance and postural stability in older adults

If you wish to try PBM for vertigo

Despite the lack of evidence, PBM applied to the mastoid area is unlikely to cause harm. If you want to experiment:

• Wavelength: 810–850nm (NIR) — Best penetration through bone
• Application: Over the mastoid process (behind the ear), bilaterally
• Dose: 20–40 J/cm² at the skin surface (recognising that the delivered dose to the inner ear will be dramatically lower)
• Duration: 5–10 minutes per side
• Frequency: Daily for 4 weeks, then reassess
• Expectations: Very low. There is no clinical evidence this will help

When to see a doctor immediately

• First episode of vertigo (especially if sudden and severe)
• Vertigo with hearing loss, tinnitus, or aural fullness
• Vertigo with headache, visual changes, or neurological symptoms
• Vertigo after head injury
• Persistent vertigo lasting more than 48 hours

The bottom line

Red light therapy for vertigo has no clinical evidence base. The theoretical rationale is weak, primarily because the vestibular apparatus is encased in dense bone that substantially blocks light penetration. The most common cause of vertigo (BPPV) is a mechanical problem that responds to physical repositioning manoeuvres, not light therapy.

If you experience vertigo, see your GP or an ENT specialist. Get a proper diagnosis. The Epley manoeuvre for BPPV is highly effective, costs nothing, and takes minutes. Vestibular rehabilitation exercises have a strong evidence base for chronic vestibular dysfunction. These are the treatments that work.

PBM is not one of them — at least not based on any evidence available today.